ArticleFrontiers in psychiatry2025
Examining suicide risk among people with schizophrenia, focusing on the role of anosognosia and the ethical considerations for future research directions.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The intermediate role of impulsive personality traits between attention-deficit/hyperactivity disorder symptoms and suicidal ideation among patients with schizophrenia.PCN reports : psychiatry and clinical neurosciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This perspective paper discusses the primary risk factors consistently identified in systematic reviews of suicide among individuals with schizophrenia. Particular attention is given to the intricate relationship between anosognosia (lack of insight into one's illness) and suicide risk in this population. This paper explores how anosognosia may influence other established risk factors and potentially contribute to suicidal behavior in patients with schizophrenia. By analyzing this complex interplay, this paper aims to provide a more comprehensive understanding of suicide risk in schizophrenia, potentially informing more effective prevention strategies and interventions for this vulnerable group. Future research in this area should carefully consider the ethical implications, including the potential impact of interventions on individuals with varying levels of insight into their condition. Researchers must prioritize participant safety and well-being while balancing the need to advance knowledge in this critical field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.